Short answer · Medically reviewed summary · Last updated: 2026-04-07
Spinal Muscular Atrophy (SMA) is a group of hereditary diseases characterized by the progressive loss of motor neurons, most commonly referred to by the clinical classification of its subtypes (SMA Type 1 through Type 4). While historically known by various eponymous names based on the physicians who first described specific presentations, Spinal Muscular Atrophy is the universally accepted medical term used in modern clinical practice and diagnostic coding. What are the historical and alternative names for Spinal Muscular Atrophy? Historically, Spinal Muscular Atrophy was often identified by the names of the clinicians who published early case reports.
Spinal Muscular Atrophy (SMA) is a group of hereditary diseases characterized by the progressive loss of motor neurons, most commonly referred to by the clinical classification of its subtypes (SMA Type 1 through Type 4). While historically known by various eponymous names based on the physicians who first described specific presentations, Spinal Muscular Atrophy is the universally accepted medical term used in modern clinical practice and diagnostic coding.
Historically, Spinal Muscular Atrophy was often identified by the names of the clinicians who published early case reports. You may encounter these terms in older medical literature or older patient records. The most common historical synonym is Werdnig-Hoffmann disease, which specifically refers to the infantile-onset form (SMA Type 1). Another term occasionally found in archival texts is Kugelberg-Welander disease, which typically refers to the milder, later-onset form (SMA Type 3). While these eponymous names were vital for early identification, they are now considered outdated, as the medical community has shifted to the more precise, genetically-based classification system.
In contemporary medicine, Spinal Muscular Atrophy is categorized by its genetic cause—usually a deletion or mutation in the SMN1 gene—and its clinical severity. Major medical classification systems utilize the following identifiers:
Using the term Spinal Muscular Atrophy ensures consistency across international borders, as it describes the fundamental pathology: the degeneration of alpha motor neurons in the anterior horn of the spinal cord.
The variety of names for Spinal Muscular Atrophy stems from the evolution of medical knowledge. Before the discovery of the SMN1 gene in 1995, clinicians could only classify the disease based on physical symptoms and age of onset. This led to fragmented naming conventions based on observed clinical presentations. As genetic testing became the gold standard, the medical field consolidated these disparate labels into a single, unified diagnosis. Today, 972 people with Spinal Muscular Atrophy within the DiseaseMaps community connect under this singular, accurate terminology, which helps streamline care and improve access to targeted therapies.
Modern clinicians and researchers strictly prefer the term Spinal Muscular Atrophy. Using this standardized name facilitates clear communication between neurologists, geneticists, and families. It is important to note that while "SMA" is the standard abbreviation, it is always best to use the full name in official documentation to avoid confusion with other conditions that may share the same acronym in different medical specialties.
Medical Disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.